The vaccine developed by the Swedish pharmaceutical company AstraZeneca and researchers from the Oxford University It has been the one that has generated the most controversy since vaccination began around the world last December.
In early March, several countries in the European Union decided to stop vaccination with this drug because some had been detected thrombosis cases in people who had received the first dose of the Anglo-Swedish drug. Spain was one of them. However, after the European Medicines Agency (EMA) confirmed the effectiveness of the vaccine and ensured that its benefits far outweighed the risks, it was decided to continue with the vaccination.
However, at the end of last week the EMA assured that there is a relationship between the AstraZeneca vaccine and cases of thrombosis. These, although very rare, can occur with higher probability in women under 50 years of age.
After this communication, and with the positive results of the effectiveness of this vaccine in people over 55 years of age, the Ministry of Health Spanish has announced that soon these doses will go to people between 60 and 69 years.
And what are they doing in other countries?
Countries that have changed their vaccination criteria with AstraZeneca
Following the announcement of the EMA, several countries have decided change your vaccination criteria with AstraZeneca .
Spain has decided to stop administering the doses to those under 60 years of age, something that countries such as Italy and Portugal.
For its part, Netherlands, Germany and Finland They also apply that age limit, although this decision came before the announcement of the European Medicines Agency.
France and Belgium they extend the age limit a little more to 55.
Countries that do not vaccinate with AstraZeneca
Denmark, one of the first countries to stop vaccination with AstraZeneca after the detection of at least 30 cases of thrombi in its territory in people who had received the first dose of the Anglo-Swedish vaccine, have decided not to resume vaccination until studies that are being carried out confirm the safety of the vaccine.
On the other hand Norway has also decided to discontinue vaccination with AstraZeneca for the time being.
The case of the United Kingdom
UK It is the country that has administered the most doses of the AstraZeneca vaccine so far.
The British Prime Minister, Boris Johnson He has stated that he has no doubts about the vaccine and that it will continue to be administered normally in people over 30. Those younger may choose to choose this drug or wait for another vaccine.